Benzinga | Nov 15, 2021 10:59AM EST

RBC Capital Maintains Outperform on Teladoc Health, Lowers Price Target to $215

RBC Capital analyst Sean Dodge maintains Teladoc Health (NYSE:TDOC) with a Outperform and lowers the price target from $260 to $215.